Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
10
NCT00578565
Rituximab in Rheumatoid Arthritis Lung Disease
Phase: Phase 3
Role: Lead Sponsor
Start: May 31, 2007
Completion: Jun 30, 2011